Rifapentine, a broad-spectrum antibiotic, plays a crucial role in treating and preventing tuberculosis (TB). With the rising global burden of TB, the demand for Rifapentine is expected to surge in the coming years. This presents a lucrative opportunity for manufacturers and suppliers to expand their reach and tap into new markets. Identifying Global Buyers: ASOC CIVIL IMPACTA SALUD Y EDUCACION SANOFI SYNTHELABO INDIA PRIVATE LIMITED LUPIN LIMITED MACLEODS PHARMACEUTICALS LTD WORLD HEALTH ORGANISATION РЕСПУБЛИКАНСКИЙ ЦЕНТР DOTS CÔNG TY CỔ PHẦN XUẤT NHẬP KHẨU Y TẾ VIỆT NAM TOKYO CHEMICAL INDUSTRY INDIA PRIVATE LIMITED INFECTIOUS DISEASES RESEARCH COLLABORATION LIMITED AMERICAN EMBASSY CIPLA LIMITED GHANA HEALTH SERVICE KNUST MAIN MICRO LABS LIMITED…